JP Morgan and SunGard collaborate on collateral management system

“Our new OTC derivatives collateral management service will help provide increased efficiencies for our clients,” said Murray Brown, JP Morgan’s head of derivatives collateral management. “We expect particular interest from the buy-side of the OTC derivatives market, where participants seek to outsource the non-core parts of their trading and hedging activities.”

SunGard claims its technology will result in cost savings in systems administration, personnel and IT equipment for JP Morgan, while maximising trading opportunities through the efficient updating of limits.

“This arrangement helps JP Morgan concentrate on providing a world-class derivatives service to its institutional clients,” said Juerg Hunziker, president of SunGard’s Adaptiv unit.

Effective collateral management systems have become increasingly important with the rising use of collateral for OTC derivative transactions. Collateral volumes leapt 18.4% to $1.2 trillion, according to the International Swaps and Derivatives Association’s 2005 survey published in March. The survey also found that 55% of all derivatives transactions were now underpinned by collateral, measured by volume or exposure.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Next-generation technologies and the future of trading

At a Risk.net webinar in association with capital markets technology provider Numerix, panellists discuss the potential for increased adoption of the public cloud to boost investment performance, its impact on risk management and overcoming barriers to…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here